ISHARES V PLC
IVPEF
Other OTC- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 2 Ballsbridge Park, Ballsbridge Dublin Ireland D04 YW83
- IPO Date
- May 23, 2023
- Similar Companies
- Business
- iShares V plc is an umbrella investment company with variable capital and segregated liability between its funds that issues exchange-traded funds (ETFs) tracking various equity, fixed income, commodity, and multi-asset indices; its core offerings include physically replicated UCITS ETFs such as the iShares S&P 500 EUR Hedged UCITS ETF (Acc) (ISIN: IE00B3ZW0K18, Ticker: IUSE or IVPEF), which provides EUR-hedged exposure to the S&P 500 Index for institutional and retail investors seeking accumulating returns from large-cap US equities; other key products encompass sector-specific ETFs like S&P 500 Information Technology Sector UCITS ETF, thematic funds such as iShares Europe Defence UCITS ETF, and fixed maturity iBonds ETFs targeting corporate and government bonds across regions including Europe, emerging markets, and the US. The company, incorporated in Ireland under registration number 478259 and domiciled in Dublin, serves investors across Europe with listings on major exchanges like the London Stock Exchange, Deutsche Boerse, and Borsa Italiana; it operates primarily in the European investment management segment under the management of BlackRock Asset Management Ireland Limited, with authorised participants handling primary market subscriptions and redemptions. Recent major developments include the launch of new share classes such as the iShares iBonds Dec 2029 ETF in May 2024 and the iShares Europe Defence UCITS ETF share class in July 2025, alongside prospectus updates for benchmark index changes effective December 2025 per ESMA guidelines and Board of Directors adjustments in late 2022; these expansions reflect ongoing product innovation and regulatory adaptations without notable acquisitions, funding rounds, or strategic alliances announced in 2024-2025.